<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A family with a pronounced history of venous <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombotic disease</z:e> is described </plain></SENT>
<SENT sid="1" pm="."><plain>Several members were found to have reduced antithrombin III levels </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="5" ids="28304">Heparin</z:chebi> cofactor activity was reduced in the antithrombin III-deficient plasma </plain></SENT>
<SENT sid="3" pm="."><plain>The proposita, who presented with bilateral iliofemoral vein <z:mp ids='MP_0005048'>thrombosis</z:mp> early in pregnancy, was treated initially with <z:chebi fb="5" ids="28304">heparin</z:chebi>, and after the 12th week of pregnancy was maintained on oral <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> until she was 38 weeks pregnant </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="5" ids="28304">Heparin</z:chebi> was then given and continued throughout the delivery period and for 10 days postpartum with no evidence of <z:hpo ids='HP_0004419'>recurrent thrombosis</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The effect of infusing 5 units of fresh frozen plasma on the antithrombin III level and the response to <z:chebi fb="5" ids="28304">heparin</z:chebi> were minimal and short-lived </plain></SENT>
<SENT sid="6" pm="."><plain>Oral anticoagulatns produced a rise in the antithrombin III level </plain></SENT>
<SENT sid="7" pm="."><plain>These results demonstrate the importance of maintaining antithrombin III-deficient subjects on long-term oral <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> therapy </plain></SENT>
</text></document>